XML 54 R44.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Note 8 - Financial Instruments With Off-balance-sheet Risk - Unfunded Commitments (Details) $ in Thousands | Sep. 30, 2022 USD ($)
--- | ---
Unfunded commitments, principal balance | $ 214,500
Fair value of unfunded commitment liability | 2,147
Better Place Forests Co. [Member] |
Unfunded commitments, principal balance | 5,000
Fair value of unfunded commitment liability | 6
BrightInsight, Inc. [Member] |
Unfunded commitments, principal balance | 21,000
Fair value of unfunded commitment liability | 278
Britecore Holdings, Inc. [Member] |
Unfunded commitments, principal balance | 5,000
Fair value of unfunded commitment liability | 66
Canary Medical Inc. [Member] |
Unfunded commitments, principal balance | 2,500
Fair value of unfunded commitment liability | 34
Castle Creek Biosciences [Member] |
Unfunded commitments, principal balance | 4,000
Fair value of unfunded commitment liability | 72
Ceribell, Inc. [Member] |
Unfunded commitments, principal balance | 2,500
Fair value of unfunded commitment liability | 4
Divergent Technologies, Inc. [Member] |
Unfunded commitments, principal balance | 30,000
Fair value of unfunded commitment liability | 315
DropOff, Inc. [Member] |
Unfunded commitments, principal balance | 7,500
Fair value of unfunded commitment liability | 188
Embody, Inc. [Member] |
Unfunded commitments, principal balance | 2,000
Fair value of unfunded commitment liability | 20
Engage3, LLC [Member] |
Unfunded commitments, principal balance | 8,000
Fair value of unfunded commitment liability | 40
Hound Labs, Inc. [Member] |
Unfunded commitments, principal balance | 7,500
Fair value of unfunded commitment liability | 87
Interior Define, Inc. [Member] |
Unfunded commitments, principal balance | 5,000
Fair value of unfunded commitment liability | 65
KSQ Therapeutics, Inc. [Member] |
Unfunded commitments, principal balance | 10,000
Fair value of unfunded commitment liability | 100
Lytics, Inc. [Member] |
Unfunded commitments, principal balance | 1,250
Fair value of unfunded commitment liability | 0
Magnolia Medical Technologies, Inc [Member] |
Unfunded commitments, principal balance | 10,000
Fair value of unfunded commitment liability | 122
Native Microbials, Inc. [Member] |
Unfunded commitments, principal balance | 8,750
Fair value of unfunded commitment liability | 64
Optoro, Inc. [Member] |
Unfunded commitments, principal balance | 15,000
Fair value of unfunded commitment liability | 38
PDS Biotechnology Corporation [Member] |
Unfunded commitments, principal balance | 10,000
Fair value of unfunded commitment liability | 158
Scientia Vascular, Inc. [Member] |
Unfunded commitments, principal balance | 10,000
Fair value of unfunded commitment liability | 110
Slingshot Aerospace, Inc. [Member] |
Unfunded commitments, principal balance | 5,000
Fair value of unfunded commitment liability | 64
Soli, Inc. [Member] |
Unfunded commitments, principal balance | 7,500
Fair value of unfunded commitment liability | 147
Sonex Health, Inc. [Member] |
Unfunded commitments, principal balance | 2,500
Fair value of unfunded commitment liability | 45
Swift Health Systems Inc. [Member] |
Unfunded commitments, principal balance | 25,500
Fair value of unfunded commitment liability | 105
Temperpack Technologies, Inc [Member] |
Unfunded commitments, principal balance | 9,000
Fair value of unfunded commitment liability | $ 19

X
- Definition The fair value of financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611 + Details
Name: | us-gaap_FairValueDisclosureOffbalanceSheetRisksAmountLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The face amount of financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition. + References No definition available. + Details
Name: | us-gaap_FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CastleCreekBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_EmbodyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_Engage3LLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_InteriorDefineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_LyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PdsBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_SoliIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |